100TH GENERAL ASSEMBLY
State of Illinois
2017 and 2018
SB1607

 

Introduced 2/9/2017, by Sen. Melinda Bush

 

SYNOPSIS AS INTRODUCED:
 
720 ILCS 570/316

    Amends the Illinois Controlled Substances Act. Makes a technical change in a Section concerning the prescription monitoring program.


LRB100 11093 RLC 21351 b

 

 

A BILL FOR

 

SB1607LRB100 11093 RLC 21351 b

1    AN ACT concerning criminal law.
 
2    Be it enacted by the People of the State of Illinois,
3represented in the General Assembly:
 
4    Section 5. The Illinois Controlled Substances Act is
5amended by changing Section 316 as follows:
 
6    (720 ILCS 570/316)
7    Sec. 316. Prescription monitoring program.
8    (a) The The Department must provide for a prescription
9monitoring program for Schedule II, III, IV, and V controlled
10substances that includes the following components and
11requirements:
12        (1) The dispenser must transmit to the central
13    repository, in a form and manner specified by the
14    Department, the following information:
15            (A) The recipient's name and address.
16            (B) The recipient's date of birth and gender.
17            (C) The national drug code number of the controlled
18        substance dispensed.
19            (D) The date the controlled substance is
20        dispensed.
21            (E) The quantity of the controlled substance
22        dispensed and days supply.
23            (F) The dispenser's United States Drug Enforcement

 

 

SB1607- 2 -LRB100 11093 RLC 21351 b

1        Administration registration number.
2            (G) The prescriber's United States Drug
3        Enforcement Administration registration number.
4            (H) The dates the controlled substance
5        prescription is filled.
6            (I) The payment type used to purchase the
7        controlled substance (i.e. Medicaid, cash, third party
8        insurance).
9            (J) The patient location code (i.e. home, nursing
10        home, outpatient, etc.) for the controlled substances
11        other than those filled at a retail pharmacy.
12            (K) Any additional information that may be
13        required by the department by administrative rule,
14        including but not limited to information required for
15        compliance with the criteria for electronic reporting
16        of the American Society for Automation and Pharmacy or
17        its successor.
18        (2) The information required to be transmitted under
19    this Section must be transmitted not later than the end of
20    the next business day after the date on which a controlled
21    substance is dispensed, or at such other time as may be
22    required by the Department by administrative rule.
23        (3) A dispenser must transmit the information required
24    under this Section by:
25            (A) an electronic device compatible with the
26        receiving device of the central repository;

 

 

SB1607- 3 -LRB100 11093 RLC 21351 b

1            (B) a computer diskette;
2            (C) a magnetic tape; or
3            (D) a pharmacy universal claim form or Pharmacy
4        Inventory Control form;
5        (4) The Department may impose a civil fine of up to
6    $100 per day for willful failure to report controlled
7    substance dispensing to the Prescription Monitoring
8    Program. The fine shall be calculated on no more than the
9    number of days from the time the report was required to be
10    made until the time the problem was resolved, and shall be
11    payable to the Prescription Monitoring Program.
12    (b) The Department, by rule, may include in the monitoring
13program certain other select drugs that are not included in
14Schedule II, III, IV, or V. The prescription monitoring program
15does not apply to controlled substance prescriptions as
16exempted under Section 313.
17    (c) The collection of data on select drugs and scheduled
18substances by the Prescription Monitoring Program may be used
19as a tool for addressing oversight requirements of long-term
20care institutions as set forth by Public Act 96-1372. Long-term
21care pharmacies shall transmit patient medication profiles to
22the Prescription Monitoring Program monthly or more frequently
23as established by administrative rule.
24    (d) The Department of Human Services shall appoint a
25full-time Clinical Director of the Prescription Monitoring
26Program.

 

 

SB1607- 4 -LRB100 11093 RLC 21351 b

1    (e) Within one year of the effective date of this
2amendatory Act of the 99th General Assembly, the Department
3shall adopt rules establishing pilot initiatives involving a
4cross-section of hospitals in this State to increase electronic
5integration of a hospital's electronic health record with the
6Prescription Monitoring Program on or before January 1, 2019 to
7ensure all providers have timely access to relevant
8prescription information during the treatment of their
9patients. These rules shall also establish pilots that enhance
10the electronic integration of outpatient pharmacy records with
11the Prescription Monitoring Program to allow for faster
12transmission of the information required under this Section. In
13collaboration with the Department of Human Services, the
14Prescription Monitoring Program Advisory Committee shall
15identify funding sources to support the pilot projects in this
16Section and distribution of funds shall be based on voluntary
17and incentive-based models. The rules adopted by the Department
18shall also ensure that the Department continues to monitor
19updates in Electronic Health Record Technology and how other
20states have integrated their prescription monitoring databases
21with Electronic Health Records.
22(Source: P.A. 99-480, eff. 9-9-15.)